17β-HSD8 Antibodies

Santa Cruz Biotechnology features a diverse variety of 17β-HSD8 monoclonal antibodies for advanced research in the field of steroid metabolism. 17β-HSD8 Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). 17β-HSD8, or 17β-hydroxysteroid dehydrogenase type 8, plays a crucial role in the conversion of steroid hormones, influencing their biological activity and availability. The enzyme participates in the metabolism of androgens and estrogens, making it significant in studies related to reproductive health, hormone regulation, and various endocrine disorders. Understanding 17β-HSD8 function is essential for elucidating its impact on physiological processes and potential therapeutic targets. Research applications include investigating hormone-dependent diseases, metabolic disorders, and reproductive biology. Exploring 17β-HSD8 mechanisms can lead to breakthroughs in hormone-related conditions and therapeutic development. Santa Cruz Biotechnology monoclonal antibodies for 17β-HSD8 enable researchers worldwide to advance scientific understanding of steroid biochemistry and its implications in human health.